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ABSTRACT

There is an emerging threat of Neisseria gonorrhoeae strains that are resistant to all
antibiotics. Because of this, the purpose of this research is to isolate, analyze, and partially
characterize a new inhibitor(s) of N. gonorrhoeae. Since there is an unknown molecule secreted by
Candida albicans that inhibits N. gonorrhoeae, this molecule can be partially characterized using 1H
NMR Spectroscopy to assist in the development of a new antibiotic compound. It was
hypothesized that quorum-sensing molecules, trans, trans- farnesol, tyrosol, phenylethyl alcohol,
and tryptophol, could be possible candidates for the inhibitor. Because of this, 1H NMR spectra
for these quorum-sensing molecules were obtained to serve as controls. Column chromatography
and fractionation was used to isolate the inhibitor in large scale from C. albicans grown in saltsbased media. Attempts to isolate the inhibitor in large scale, however, was unsuccessful since no
inhibition of N. gonorrhoeae was observed. Because of this, analysis of growth media was conducted
to test the media effect on producing the inhibitor. C. albicans was grown in liquid chocolate,
liquid white chocolate, salts-based, and YPD media in aerobic and candle jar environments.
Analysis of growth media in different environments suggests that liquid chocolate and salts-based
media retain the inhibitory activity. 1H NMR spectra were obtained for the isolated molecule in
liquid chocolate and salts-based media in both aerobic and candle jar environments. Analysis of
this 1H NMR suggested that the inhibitor could be isolated from either the aerobic or candle jar
environment for both liquid chocolate and salt-based media because a clear peak between 3.5
and 4.0 ppm was observed in all spectra. Comparison of 1H NMR spectra from quorum-sensing
molecules with spectra from the isolated molecule suggests that the inhibitor is not a quorumsensing molecule. The peaks represented by the inhibitor cannot be fully characterized and thus,
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either correspond to a single molecule or a complex molecular structure. It can be concluded that
the inhibitor secreted by C. albicans to inhibit N. gonorrhoeae is a new unknown compound.
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INTRODUCTION
Gonorrhea
Neisseria gonorrhoeae is a gram-negative bacterium that causes the sexually transmitted
genitourinary infection of gonorrhea, septic arthritis, and gonococcal ophthalmia
neonatorum.[1,9,12] Of the eleven species of Neisseria that colonize humans, only two are
pathogens, N. gonorrhoeae and N. meningitides, with N. gonorrhoeae being the causative agent of
gonorrhea.[2]
This pathogen causes infections of the genitals, throat, and eyes, and, if left untreated, can
result in the infection spreading through the bloodstream to the rest of the body.[3] Untreated
infections in women can increase the incidence of secondary infection chlamydia trachomatis, a
major cause of pelvic inflammatory disease, and possibly increase infertility due to consequential
scarring.[3,4] In perinatal infections, the newborn is exposed to N. gonorrhoeae in the birth canal
leading to corneal scarring, and ultimately causing blindness.[4,5] Untreated infections in men, on
the other hand, significantly increase the risk of prostate cancer.[3,4] In addition, epidemiologic
and biologic studies provide evidence that gonococcal infections facilitate the increased
transmission of HIV infection.[6] Research conducted by Hill, et al., also showed that gonococcal
reinfection is possible because of N. gonorrhoeae ability to evade the immune system by varying its
surface proteins, manipulate immune response to generate no immune memory, and survive
within neutrophils.[6,7]
Transmission of N. gonorrhoeae occur primarily through vaginal, oral, or anal sex, with
nonsexual transmission highly unlikely.[3] Past research studies argue that the bacterium is
attached to spermatozoa; however, this conclusion does not explain female to male transmission
of the disease.[9] According to a recent study by Anderson et al., N. gonorrhoeae bacteria use pili
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(surface adhesive structures) to anchor onto proteins in the sperm to move through coital
fluid.[8,10]

A. Global Prevalence of Gonorrhea
Gonorrhea is a disease of worldwide importance.[7,12] The World Health Organization
estimated the global prevalence and incidence of gonorrhea as 62.34 million in 2000 (Figure
1).[11,12] Based on prevalence data from 2005, figures in 2012 correspond to an estimate of 78
million new cases of gonorrhea globally.[13]

11

Figure 1. Global Estimate of New Cases of Gonorrhea in 2000.[12]
The Eastern Hemisphere has an increased prevalence of gonorrhea, with India and Africa
estimating over 44.23 million cases.

12

B. National Prevalence of Gonorrhea
Gonorrhea is the second most commonly reported notifiable disease in the United
States.[12,14] Between 1946 and 1956, there was a reduction of reported cases of gonorrhea in the
United States (Figure 2). An increase of reported cases of gonorrhea was seen from 1961 and 1976
(Figure 2), a trend that coincided with the onset and ending of the Vietnam War and the sexual
revolution of the 1960s. Data shows that it took the United States nearly twenty years for the
incidence of gonorrhea to return to levels not seen since 1956.[14] From 2008 to 2017, the reported
cases of gonorrhea trend higher in the southern regions of the United States, just above the rates
seen in the Midwest (Figure 3).[14] In the past five years, rates have increased significantly in the
West (Figure 3).[14] A high rate of infections per 100,000 population remain persistent in certain
geographic area and is largely attributable to increases among men, young adults, and some ethnic
groups (Figure 4).[14] Rates of reported gonorrhea remain high among Blacks with 548.1 cases per
100,000 population followed by Hispanics with 113.7 cases per 100,000 population.[14]
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Figure 2. Rates of Reported Gonorrhea cases in the United States from 1941-2017.[14]
The national rate of reported gonorrhea cases reached a historic low in 2009 but increased each
year during 2009-2012.[14] The reported cases of gonorrhea decreased slightly in 2013; however,
the national rate of gonorrhea cases reported has steadily increased from 2014-2016. During 20162017, the rate of gonorrhea cases increased 18.6%, and 75.2% since the historic low in 2009.[14] A
total of 555,608 cases of gonorrhea were reported in 2017, yielding a rate of 171.9 cases per
100,000 population.[14]
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Figure 3. Rates of Reported Gonorrhea cases by Region in the United States from
2008-2017.[14]
According to the 2017 Sexually Transmitted Disease Surveillance, the South has the highest rate
of reported gonorrhea cases with 194 cases per 100,000 population.[14] During 2016-2017, the
gonorrhea rate increased 19.9% in the West, 10.5% in the Midwest, 19.0% in the Northwest, and
17.5% in the South.[14]
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Figure 4. Rates of Reported Gonorrhea cases by State in the United States in 2017.[14]
In 2017, rates of reported gonorrhea cases were 32.5 per 100,000 population in Vermont to 309.8
per 100,000 population in Mississippi and 669.9 per 100,000 in the District of Columbia.[14]
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C. Current Treatment for Gonorrhea
The Center for Disease Control and Prevention recommends a dual antibiotic
therapy.[14,15] This includes a single dosage of ceftriaxone along with azithromycin.[14,15]
Azithromycin is added in the case that N. Gonorrhoeae is resistant to cephalosporin, but susceptive to
macrolides.[14,15] In many cases, however, symptoms persist after receiving these antibiotic
treatments for N. gonorrhoeae infection.[15]

Neisseria gonorrhoeae
Neisseria gonorrhoeae is a diplococci gram-negative bacterium.[12] This bacterium is
facultatively intracellular, oxidase positive, and aerobic.[1,12] Although this bacterium is aerobic,
culturing gonococcal strains requires nutrient supplementation.[12]

A. Antibiotic Resistance for Neisseria gonorrhoeae
N. gonorrhoeae has progressively developed resistance since 1940.[16] In the early 1940s,
gonorrhea was treated with penicillin; however, doses had to be progressively increased to
remain effective.[16,17] By 1970, penicillin-resistant gonorrhea emerged in the Pacific Basin,
spreading to Hawaii, California, and the rest of the United States and Europe.[17] Because of the
increasing incidence of penicillin resistance in N. gonorrhoeae, penicillin was no longer used as an
antibiotic of choice for the initial treatment of gonorrhea.[16,17] Emerging research introduced
fluoroquinolones as a potential inhibitor of N. gonorrhoeae; yet, by 2007, fluoroquinolones became
resistant.[16, 17] Fluoroquinolones lack of inhibition began in the late 1990s into the early part of
the 21st century.[16,17] By 2007, N. gonorrhoeae had developed another mutation that allowed it to
evade the killing activity of fluoroquinolones.[16] Since 2007, the Center for Disease Controls and
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Prevention named the standard treatment for gonorrhea as third-generation cephalosporins, such
as ceftriaxone, along with azithromycin.[17,18] This standard treatment is considered today as the
“last line of defense” against N. gonorrhoeae.

B. Decrease in Susceptibility to Ceftriaxone and Azithromycin
Susceptibility testing for ceftriaxone began in 1987.[14,18] Data from the World Health
Organization and Gonococcal Antimicrobial Surveillance Program shows a decline in the
susceptibility of ceftriaxone, resulting in the change to a standard treatment mandated by the
Center for Disease Controls and Prevention (Figure 5).[14,18] A dual treatment with ceftriaxone
and azithromycin is now recommended because of increased ceftriaxone resistance. [15] Although
azithromycin was added to inhibit N. gonorrhoeae, figures illustrate the decrease in susceptibility to
azithromycin globally (Figure 6).[18]
This emerging threat of ceftriaxone and increased azithromycin resistance highlights the
need for continued research and surveillance of N. gonorrhoeae antibiotic susceptibility.[14,18] The
treatment of antibiotic resistant N. gonorrhoeae reinforces the need to find an inhibitor to N.
gonorrhoeae.[7,14,18] Today, the Gonococcal Antimicrobial Surveillance Program continues to
monitor for the emergence of resistance to ceftriaxone and azithromycin.[18]
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Figure 5. Percent Resistance or Decrease in Susceptibility to Ceftriaxone in
2014.[18]
In 2017, it was observed that a decrease in susceptibility to ceftriaxone had been identified in San
Diego, California; Cincinnati, Ohio; Philadelphia, Pennsylvania; and Oklahoma City,
Oklahoma.[14] A high decrease in susceptibility to ceftriaxone is noted predominately in Asia,
Australia, North America, and South America.[18]
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Figure 6. Percent Resistance or Decrease in Susceptibility to Azithromycin in
2014.[18]
In 2014, research showed an emerging resistance to azithromycin with a decreased susceptibility
in South America, Asia, Australia, and North America.
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Candida
Candida is opportunistic fungus that is a common member of the human gut flora.[19] As a
pathogenic yeast, over 20+ Candida species cause infections in humans.[20] The most common
being Candida albicans isolated from biofilms either formed on implanted medical devices or
human tissue.[20,21] Issues arise when overgrowth of this species causes a commonly known
infection called candidiasis. C. albicans, C. tropicalis, C. parapsilosis, and C. glabrata are together
responsible for 50-90% of candidiasis in humans.[22]
Symptoms of candidiasis vary depending on the area of the body infected.[20] Candidiasis
developed in the mouth or throat is called “thrush” or oropharyngeal candidiasis, while
candidiasis in the vagina is commonly referred to as an yeast infection.[20] Invasive candidiasis, on
the other hand, occurs when Candida species enter the bloodstream and spread throughout the
body—this condition is often fatal and seen in patients whose immune functions are
suppressed.[20]

Quorum Sensing Molecules in Candida albicans
Quorum-sensing is a mechanism of microbial communication that can regulate several
behaviors in bacteria such as the secretion of virulence factors, formation of biofilms,
competence, and bioluminescence.[23] Quorum sensing molecules can impact a single species
behavior or can be messengers between different species.[23] Candida albicans secretes the following
quorum-sensing molecules: farnesol, tyrosol, phenylethyl alcohol, and tryptophol, which can
impact its virulence behavior.
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A. trans, trans-Farnesol
Trans, trans-farnesol is a quorum-sensing molecule produced by C. albicans that blocks
germ tube formation (Figure 7).[24] Trans, trans-farnesol is a sesquiterpene alcohol (3, 7, 11trimethyl-2,6,10-docdecatriene-1-ol).[24] This quorum sensing molecule has shown in recent
studies to affect the growth of a number of bacteria and fungi, pointing to a potential role as an
antimicrobial agent.[23,24] Farnesol is also the major quorum sensing molecule that C. albicans uses
to regulate its morphogenesis. At physiological levels, farnesol is around 30 µM.[24]

B. Tyrosol
Tyrosol (2-[4-hydroxyphenyl] ethanol) is a derivative of the amino acid tyrosine and was
subsequently identified as the second quorum-sensing molecules in C. albicans (Figure 8).[25,26]
This compound is released into the growth medium and accelerates the formation of germ
tubes.[26] According to research conducted by Alem et al., tyrosol production in C. albicans is
between 7 µM and 13.6 µM.[26] Though tyrosol induces germ tube formation, its affects are
overridden by the presence of farnesol.

C. Phenylethyl alcohol
Phenylethyl alcohol was one of the first aromatic alcohol molecule to be identified in C.
albicans (Figure 9).[27, 31] At physiologically levels, phenylethyl alcohol is around 10 µM. [31] Once
its concentration reaches this threshold value, this molecule is known to inhibit both growth and
germ tube formation.[27, 31]
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D. Tryptophol
Tryptophol, an indoyl aromatic alcohol, is a derivative of the amino acid tryptophan
whose production in C. albicans is dependent on growth conditions (Figure 10).[27] At physiological
levels, tryptophol is around 10 µM.[27, 31] Tryptophol is known to have the same role as
phenylethyl alcohol.
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24

Interactions Between Candida and Neisseria gonorrhoeae
After testing seventy-seven different microorganisms such as Staphylococcus epidermidis, S.
aureus, Candida albicans, Strepococcus viridans, Lactobacillus, Staphylococcus epidermidis, and
Peptostreptococcus for inhibitory activity, Kaye and Levison confirmed that C. albicans and S.
epidermidis showed inhibition of N. gonorrhoeae.[28] The study then focused on select bacterial
species, S. epidermidis, S. aureua, C. albicans, P. asaccharolyticus, Fusobacterium varium, Clostridum tertium,
and “Gaffkya anaerobia.”[28] These bacterial species were tested on nine strains of N. gonorrhoeae to
further determine inhibition of gonococcal strains. No strains of Peptostreptococcus or Lactobacillus
demonstrated inhibition; however, three strains of S. epidermidis, S. aureus, and Candida
demonstrated inhibition.[28] Hipp et al. noted that S. epidermidis inhibited not only one strain of N.
gonorrhoeae, but all nine strains, whereas C. albicans had marked variation in inhibitory activity
amoung the gonococcal strains.[29]
Hipp et al. demonstrated that C. albicans can inhibit the growth of N. gonorrhoeae.[29] Five
different isolates of yeasts, C. albicans, C. tropicalis, C. parapsilosis, C. glabrata, and Trichosporon
cutaneum, were also tested for inhibitory activity; however, not all Candida species inhibit N.
gonorrhoeae.[29] Results showed that strains of C. albicans had inhibitory activity against the
gonococcal strains tested.[29] A total of fifty-one C. albicans isolates showed inhibitory activity
against N. gonorrhoeae, proving successful replication of inhibition.[29]
One study observed the selective interaction of N. gonorrhoeae and C. albicans and its
possible role in proper handling of clinical specimens.[32] A study of twenty-seven clinical
specimens from patients with signs of gonococcal infection had C. albicans isolated from gut flora
to test inhibition.[32] Results showed that these gonococcal isolates from clinical specimens were
mildly resistant to inhibition by the isolated C. albicans, while laboratory C. albicans strains were
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more inhibitory.[32] Even though the inhibitory interaction between C. albicans from clinical
specimens infected with gonorrhea is selective, the important aspect of this study is that C. albicans
can inhibit in vitro the growth of N. gonorrhoeae.[32]

A. Isolation of Inhibiting Factor in Candida albicans
It appears that this inhibiting factor can be extracted from the cells and lyophilized. The
retention from dialysis tubing suggests that the inhibiting factor has a molecular size between
3,000 and 9,000 Da (Personal comm.-Dr. Kruppa). Previous attempts to extract the inhibitory
factor were conducted using tertiary butyl alcohol in 100 mL distilled water but the molecule was
never identified. An important aspect of the research study conducted was that this is the first
time that an inhibitory substance to a bacterium had been isolated from C. albicans.

B. Identifying Inhibiting Factor in Candida albicans
Hipp et al. observed that a soluble factor produced by C. albicans inhibits the growth of
the majority of N. gonorrhoeae strains.[29] Past research studies in the Kruppa lab hypothesized that
candidalysin, a toxin produced in Candida species, was the inhibitor of N. gonorrhoeae; however, a
mutant strain lacking the toxin still showed inhibition (Personal comm.-Dr. Kruppa). These
findings suggest that the inhibitor of N. gonorrhoeae is likely an uncharacterized compound.[30]

NMR Spectroscopy
Nuclear Magnetic Resonance (NMR) Spectroscopy is based on the principle that atomic
nuclei with an odd mass are electrically charged and have magnetic moments (nuclear spins) that
are randomly oriented.[33] When these atomic nuclei are placed in a magnetic field, the magnetic
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moments either align with or opposite to the direction of the magnetic field.[33, 34] Atomic nuclei
aligned with the magnetic field are in the lower energy alpha state (a-state), while excited nuclei
enter the high energy beta state (b-state) when energy is transferred.[34] Absorption of energy
results in an energy gap that corresponds to different frequencies.[33, 34] While the magnetic
moment can be affected by an applied magnetic field, it can also be affected by nearby atoms
that also possess magnetic moments.
An NMR spectrum is a plot of frequency vs. absorption of energy. Since NMR
spectrometers operate at different magnetic field strengths, a standardized method using an
arbitrary variable chemical shift with units of parts per million (ppm) is utilized.[33] Chemical shift
is plotted on the x-axis ranging from 0 to 10 ppm in 1H NMR.[34]
When determining the connectivity of a compounds using NMR, two isotopes are
primarily used: 1H and 13C.[33] Two-dimensional 1H -1H NMR spectroscopy, also known as
Correlated Spectroscopy (COSY), is a useful method that can determine which signals arise from
neighboring protons.[35]

Basis of Study
Since there is an unknown molecule secreted by Candida albicans that inhibits N. gonorrhoeae,
this molecule can be isolated, analyzed, and characterized to assist in the development of a new
antibiotic compound. Quorum-sensing molecules, farnesol, tyrosol, phenylethyl alcohol, and
tryptophol, are some possible candidates for this unknown compound. As noted in the Kruppa
lab, the estimated molecular size of the inhibitory factor is smaller than these quorum-sensing
molecules. These molecules, however, cannot be eliminated as possible candidates. Previous
work by in the Kruppa lab demonstrated that farnesol could be carried on small vesicles secreted
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by C. albicans.[36] Since farnesol can be carried on small vesicles, it is possible that fragments of
these vesicles are masking the size of the inhibitor. Therefore, this study will test the inhibitory
activity of quorum-sensing molecules, isolate the inhibitor from C. albicans salt-based medium via
column chromatography, analyze the effect of growth media on inhibitor activity, and partially
characterize the isolated molecules by 1H NMR spectroscopy. The 1H NMR spectra from these
isolated molecules will be compared to signatures from the quorum-sensing molecules secreted by
C. albicans to affirm whether the inhibitor is a new compound or possibly a combination of known
molecules.
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MATERIALS AND METHODS
Cultivation and Maintenance of Neisseria gonorrhoeae Strains
In this study, the following three strains of Neisseria gonorrhoeae were used: ATCC 31426,
ATCC 43070, and ATCC 19424. These strains were maintained in a low oxygen tension
environment (candle jar) and incubated in a 37°C on chocolate agar media. When testing the
inhibitory factor secreted by Candida albicans, the N. gonorrhoeae strains were grown on white
chocolate agar media.

A. Chocolate Agar Media
Chocolate agar consists of hemoglobin, gonococcus (GC) medium base, and distilled
water. Two separate solutions, Solution I (Hemoglobin solution) and Solution II (GC Agar Base
solution), were mixed to form chocolate agar. Solution I consisted of 5 grams hemoglobin and
250 mL distilled water. This Hemoglobin solution was stirred for 15-20 minutes and covered
with a layer of cheese cloth and aluminum foil. Once the hemoglobin had completed dissolved
into the distilled water, the Hemoglobin solution was sterilized for 15 minutes at 121°C. After
sterilization, the solution was cooled in a 50-55°C water bath for 30-40 minutes. Solution II
consisted of 18 grams GC medium base and 250 mL distilled water. This GC Agar Base solution
was boiled and sterilized for 15 minutes at 121°C. After sterilization, the solution was cooled in a
50-55°C water bath for 30-40 minutes. While maintaining sterility, the cooled Hemoglobin
solution was added to the cooled GC Agar Base solution with 5mL of Isovitalex (BectonDichenson). The combined solution was mixed thoroughly and poured onto plates. Liquid
preparations lack GC Agar Base and were distributed in 5 mL aliquots.
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B. White Chocolate Agar Media
Similar to chocolate agar, white chocolate agar consists of hemoglobin, GC medium base,
and distilled water. Two solutions, Solution I (Hemoglobin solution) and Solution II (GC Agar
Base solution), were mixed to form white chocolate agar. When preparing the white chocolate
agar media, the Hemoglobin solution consists of 0.5 grams of hemoglobin and 250 mL of
distilled water. This Hemoglobin solution was then prepared similar to the methodology used for
chocolate agar. The GC Agar Base solution was also prepared analogous to the preparation
utilized for the chocolate agar. While maintaining sterility, the cooled Hemoglobin solution was
added to the cooled GC Agar Base solution with 5mL of Isovitalex. The combined solution was
mixed thoroughly and poured onto plates. Liquid preparations lack GC Agar Base and were
distributed in 5 mL aliquots.

Cultivation and Maintenance of Candida albicans Strains
In this study, wild type strain SC5314 of Candida albicans was used. C. albicans was
maintained on YPD (2% yeast extract, 2% peptone, and 1% dextrose). C. albicans was also grown
in salts-based media (15 grams of glucose, 2 grams NH4Cl, 2 grams KH2PO4, 0.05 grams CaCl•
2H2O, 0.05 grams MgSO4 • 7H2O, 1 milligram ZnSO4 • 7H2O, 1 milligram CuSO4 • 5H2O,
and 25 µg Biotin dissolved in 1 L of distilled water). The solution was then filter sterilized using
0.45 µg filter flask for inhibitor isolation.
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Characterizing the Quorum-Sensing Molecules secreted by Candida albicans
Using 1H NMR Spectroscopy
A 400 MHz 1H NMR spectroscopy was used to characterize the quorum-sensing
molecules, farnesol, tyrosol, phenylethyl alcohol, and tryptophol. Deuterated chloroform (CDCl3)
was used as the solvent for testing trans, trans-farnesol, phenylethyl alcohol, and tryptophol, while
deuterated oxide (D2O) was used as the solvent for tyrosol. For the NMR, 25 scans were run for
tyrosol, phenylethyl alcohol, and tryptophol and 102 scans were run for trans, trans-farnesol. All
1H NMR

spectroscopy was conducted at 294.7 K.

Testing for Inhibition of Neisseria gonorrhoeae through Quorum-Sensing
Molecules secreted by Candida albicans
The interaction of quorum-sensing molecules secreted by C. albicans with N. gonorrhoeae
was tested by obtaining the following quorum-sensing molecules: farnesol, tyrosol, phenylethyl
alcohol, and tryptophol, at physiological levels. Three trials were conducted to determine if
quorum-sensing molecules can inhibit gonococcal growth.
To obtain farnesol at physiological levels, 6.25 µL was dissolved into 1 mL of ethanol. In
order to further dilute, 1 µL of farnesol was added to 1 mL of distilled water, forming a 300 mM
concentrated farnesol solution. In a final test tube, 100 µL of farnesol and 900 µL of distilled
water were mixed to produce a 30 µM solution of farnesol.
In order to obtain tyrosol at physiological levels, 20 milligrams of tyrosol was dissolved in
1 mL of water. In a final test tube, 900 µL of water and 100 µL tyrosol was combined to produce
a 10 µM solution of tyrosol.
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In a test tube, 2.8 µL of phenylethyl alcohol was mixed with 1 mL water. In a final test
tube, 900 µL of water and 100 µL phenylethyl alcohol was combined to produce a 10 µM
solution of phenylethyl alcohol.
To obtain tryptophol at physiological levels, 20 milligrams of tryptophol was dissolved in
1 mL ethanol. In a final test tube, 900 µL of water and 100 µL tryptophol was combined to
produce a 10 µM solution of tryptophol.
N. gonorrhoeae strain ATCC 43070 was inoculated into a liquid chocolate agar and grown
in a candle jar environment at 37°C. After two days, the gonococcal cells were diluted and
spread over three separate white chocolate agar plates according to the following dilutions: 1:10,
1:100, and undiluted. Ten microliters of farnesol, tyrosol, phenylethyl alcohol, and tryptophol
were then spotted on the plates and placed in a candle jar environment at 37°C. Inhibition was
analyzed after two days and results were recorded.

Column Chromatography to Isolate Inhibitor from C. albicans Salts-Based
Medium
To isolate the inhibitory factor, a 250 mL bed G150 Sephadex column was used. The
column matrix was prepared using 15 grams of Sephadex 130 beads dissolved in 400 mL of
double distilled water. The Sephadex beads were allowed to swell overnight and were then
placed in the column. Excess water was drained, and a test run was conducted to estimate the
time for the column run. A 250 mL sample of C. albicans grown in salts-based media was filter
sterilized and loaded onto the column. An equivalent “flow thru load” was collected. Fractions
were then collected using a Bio-Rad fraction collector. For each 250 mL sample, 50 fractions
were collected with 5 mL in each test tube. All fractions were stored in 4°C cold storage. Once
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the fractions were collected, the column was washed using double distilled water and prepared to
load the next 250 mL sample. The column chromatography was conducted in 4°C cold storage.
This was repeated for five 1L samples. Fraction were stored at -20°C until used for inhibitor
testing.

Testing for Inhibitor from Candida albicans grown in Salts-Based Media with
Neisseria gonorrhoeae
All three strains for N. gonorrhoeae were inoculated into three liquid chocolate agar tubes
and grown in a candle jar environment at 37°C. After two days, 150 µL of each strain was
spread onto three separate white chocolate agar plates. 1 mL of each fraction collected by
column chromatography was placed onto a 48-well plate along with 1 mL of the “flow thru
load”. 5 µL of each fraction and the “flow thru load” were spotted onto each agar plate. After
spotting each strain, the plates were allowed to grow in 5% CO2 (using BD Gaspak CO2
generator) and incubated at 37°C. Inhibition was analyzed after two days and results were
recorded. This was repeated for all five 1L samples.

Testing for Effect of Growth Media on Candida albicans Ability to Inhibit
Neisseria gonorrhoeae
All three strains for N. gonorrhoeae were inoculated into three liquid chocolate agar tubes
and grown in a candle jar environment at 37°C. After two days, 150 µL of each strain was
spread onto three separate white chocolate agar plates.
C. albicans was grown in two tubes of 10 mL liquid white chocolate, 10 mL liquid
chocolate, 10 mL YPD, and 10 mL salts-based media. Four test tubes containing liquid white
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chocolate, liquid chocolate, YPD, and salts-based media were grown in a candle jar
environment, while the other four test tubes were grown in an aerobic environment. All test tubes
were incubated at 37°C. After two days, the various media were filtered through a 0.45 µm
Nalgene syringe filter to remove Candida cells. The filtered media was centrifuged using a 10,000
Da cutoff filter tube and the “flow thru” was collectd. The “flow thru” was dialyzed in water
using 3,000 Da cutoff slide-A-lyzer to desalt. The dialyzed material was used for NMR analysis.
To test for inhibition, 5 µL of the dialyzed spent liquid white chocolate, spent liquid
chocolate, spent YPD, and spent salts-based media from both the candle jar and aerobic
environment were spotted onto each white chocolate agar plate. After spotting onto the N.
gonorrhoeae, the plates were allowed to grow in 5% CO2 Gaspak generated environment and
incubated at 37°C. Inhibition was analyzed after two days and results were recorded. This was
repeated for three sets of the various dialyzed spent media.

Partial Characterization of the Inhibitor secreted by Candida albicans Using NMR
Spectroscopy
A 400 MHz 1H NMR Spectroscopy was used to characterize isolated molecules that
showed inhibition of N. gonorrohoeae. The inhibitor was partially characterized using deuterated
oxide (D2O). The signatures from the isolated molecules were compared to signatures of the
quorum-sensing molecules C. albicans secretes to determine whether the inhibitor is a new
compound or combination of known compounds.
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RESULTS AND DISCUSSION
Testing for Inhibition of Neisseria gonorrhoeae through Quorum-Sensing
Molecules secreted by Candida albicans
Since there is an unknown molecule secreted by C. albicans that inhibits N. gonorrhoeae, this
molecule must be characterized to assist in the development of a new antibiotic compound. The
purpose of this study is to isolate, analyze, and partially characterize the inhibitor to affirm
whether the inhibitor is a new compound or possibly a combination of known molecules. The
Kruppa lab noted that the estimated molecular size of the inhibitory factor is between 3,000 and
9,000 Da—smaller than that of the quorum-sensing molecules. Quorum-sensing molecules,
however, cannot be eliminated as possible candidates for the inhibitor because previous work in
the Kruppa lab demonstrated that farnesol could be carried on small vesicles secreted by C.
albicans.[36] Since farnesol can be carried on small vesicles, it is possible that fragments of these
vesicles are masking the size of the inhibitor.
Quorum-sensing molecules, farnesol, tyrosol, phenyethyl alcohol, and tryptophol, are
some possible candidates for this unknown compound. For this reason, 1H NMR Spectrum was
obtained for all four quorum-sensing molecules to serve as controls (Figure 11-14).
To verify that these quorum-sensing molecules did not inhibit gonococcal growth, all four
quorum-sensing molecules were tested at physiological levels for inhibition (trans, trans-farnesol,
30 µM; tyrosol, 10 µM; phenylethyl alcohol, 10 µm; and tryptophol, 10 µM). No inhibitory
activity was observed for the quorum-sensing molecules (Table 1). This suggests that a different
molecule is involved in the inhibition of N. gonorrhoeae.
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Quorum-sensing Molecules

Gonococcal Growth

trans, trans-Farnesol

+/+

Tyrosol

+/+

Phenylethyl alcohol

+/+

Tryptophol

+/+

Table 1. Inhibition of Neisseria gonorrhoeae through Quorum-Sensing Molecules
secreted by Candida albicans.
N. gonorrhoeae strain ATCC 43070 was used to test inhibition through quorum-sensing molecules.
Gonococcal growth was recorded after each molecule was spotted onto the N. gonorrhoeae. No
inhibitory activity was recorded for the quorum-sensing molecules secreted by C. albicans.
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Column Chromatography to Isolate Inhibitor from Candida albicans Salts-Based
Medium
Previous research in the Kruppa lab attempted to isolate the inhibitory molecule secreted
by C. albicans. C. albicans, grown in liquid chocolate agar, was isolated using a 10 mL bed column;
however, the inhibitor was isolated at low concentrations. Since the inhibitor was dilute, NMR
analysis was inconclusive. The dilute nature of the inhibitor suggested that the inhibitor may be a
glycopeptide or a polysaccharide. To concentrate the amount of inhibitor secreted by C. albicans,
it was hypothesized that a 250 mL bed column can be used for large scale-up. It was also
hypothesized that a clear conclusive NMR signal can be obtained using salts-based media instead
of liquid chocolate agar to grow C. albicans. The use of salts-based media allows for the detection
of molecules secreted by C. albicans versus when it is grown in liquid chocolate agar, which has a
large number of proteins that could interfere or complicate inhibitor isolation.
Five 1 L samples of C.albicans grown in salts-based media were fractionated. Fractions
from each sample was tested for inhibition to determine which fractions potentially contained the
inhibitory molecule. However, no inhibitory activity was observed when testing the interaction of
C. albicans grown in salts-based media with N. gonorrhoeae. It is possible that large scale-up using
column chromatography caused the inhibitor to be lost, diluted throughout the fractions, or
bound to the Sephadex column, resulting in no inhibitory activity when fractions from these
samples were tested. Another possibility is that the salts-based media is not an appropriate
medium to yield sufficient inhibitory activity.
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Testing for Effect of Growth Media on Candida albicans Ability to Inhibit
Neisseria gonorrhoeae
Previous work in the Kruppa lab used liquid chocolate agar to grow C. albicans. Since no
inhibition of N. gonorrhoeae was observed when C. albicans was grown in salts-based media used in
column chromatography, the effect of growth media on C. albicans ability to inhibit N. gonorrhoeae
was tested.
Growth media, liquid chocolate agar, liquid white chocolate agar, salts-based media, and
YPD, were used to grow C. albicans and test its ability to inhibit N. gonorrhoeae. It was observed that
salts-based media inhibited N. gonorrhoeae strain ATCC 31426, YPD showed no inhibitory
activity, and liquid white chocolate and chocolate agar had moderate inhibition (Table 2). For N.
gonorrhoeae strain ATCC 43070, liquid chocolate agar, salts-based media, and YPD showed no
inhibitory activity, while liquid chocolate agar showed moderate inhibition (Table 3). These
results suggests that selective inhibition to N. gonorrhoeae can occur because different strains can
have varied susceptibility to the inhibitor secreted by C. albicans.
Analysis of growth media on C. albicans ability to inhibit N. gonorrhoeae suggests that saltsbased media and liquid chocolate agar retain inhibitory activity, while YPD and liquid white
chocolate agar show minimal to no inhibition. Therefore, the salts-based media is capable of
being used to isolate the inhibitory molecule. This may suggest that the scale up in column
volume and fractionation resulted in severe dilution of the inhibitory activity. Because of this, it
may be necessary to alter the approach to isolate a large amount of the inhibitor.
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Growth Media
Trials

Environment

1

2

3

aerobic

Liquid
Chocolate
+/-

Liquid White
Chocolate
+/-

Salts-Based
Media
+/-

YPD
+/+

candle jar

+/-

+/-

-/-

+/+

aerobic

+/-

+/-

-/-

+/+

candle jar

+/-

+/-

-/-

+/+

aerobic

+/-

+/-

-/-

+/+

candle jar

+/-

+/-

-/-

+/+

Table 2. Effect of Growth Media on Candida albicans Ability to Inhibit Neisseria
gonorrhoeae ATCC 31426.
N. gonorrhoeae strain ATCC 31426 was used to test inhibition through C. albicans grown on various
media. Gonococcal growth was recorded after isolated inhibitor was spotted onto the N.
gonorrhoeae strains. Liquid chocolate agar and liquid white chocolate agar media shows moderate
inhibition. YPD showed no inhibitory activity, while salts-based media showed complete
inhibition.
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Growth Media
Trials

Environment

1

2

3

aerobic

Liquid
Chocolate
+/-

Liquid White
Chocolate
+/+

Salts-Based
Media
+/+

YPD
+/+

candle jar

+/-

+/+

+/+

+/+

aerobic

+/-

+/+

+/+

+/+

candle jar

+/-

+/+

+/+

+/+

aerobic

+/-

+/+

+/+

+/+

candle jar

+/-

+/+

+/+

+/+

Table 3. Effect of Growth Media on Candida albicans Ability to Inhibit Neisseria
gonorrhoeae ATCC 43070.
N. gonorrhoeae strain ATCC 43070 was used to test inhibition through C. albicans grown on various
media. Gonococcal growth was recorded after isolated inhibitor was spotted onto the N.
gonorrhoeae strains. Liquid chocolate agar, salts-based media, and YPD showed no inhibitory
activity, while liquid chocolate agar showed moderate inhibition.
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Partial Characterization of the Inhibitor secreted by Candida albicans Using NMR
Spectroscopy
Since C. albicans grown in liquid chocolate agar and salts-based media showed inhibitory
activity, the isolated molecule was partially characterized using 1H NMR spectroscopy (Figure
15). Analysis of the this 1H NMR, suggested that the inhibitor could be isolated from either the
aerobic or candle jar environment for both liquid chocolate and salt-based media because a clear
peak between 3.5 and 4.0 ppm was observed in all spectra (Figure 15). Comparison of 1H NMR
spectra from quorum-sensing molecules (Figure 11-14) with 1H NMR spectrum from the
inhibitor (Figure 15) suggests that the inhibitor is not a quorum-sensing molecule.
When comparing the 1H NMR spectra of the isolated molecule grown in salts-based
media with liquid chocolate agar, the C. albicans grown in liquid chocolate agar shows signatures
for proteins and the inhibitor. These proteins either correspond to proteins from the chocolate
agar or C. albicans. The signatures from salts-based media show only a clear cluster of peaks.
Previous research in the Kruppa lab suggests that the inhibitor secreted from C. albicans
was a glycopeptide; however, partial characterization conducted in this study indicates that the
inhibitor contains no sugars. The peaks represented by the inhibitor cannot be fully characterized
and can either correspond to a single molecule or a complex molecular structure. It can be
concluded that the inhibitor secreted by C. albicans to inhibit N. gonorrhoeae is a new unknown
compound. Complete characterization of the inhibitor requires further investigation to determine
if it is a single molecule or a collection of molecules. Further analysis by two-dimensional 1H-1H
NMR spectroscopy can elucidate the inhibitor structure.
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Figure 15. 1H NMR of Inhibitor secreted by Candida Albicans Grown in Chocolate
Agar and Salts-Based Media.
The inhibitor used for partial characterization showed inhibition of N. gonorrhoeae strain ATCC
31426. A 400 MHz 1H NMR was used to partially characterize and analyze the inhibitor
secreted by C.albicans grown in liquid chocolate agar and salts-based media in both an aerobic
and candle jar environment. Four 1H NMR Spectra were obtained using deuterated oxide as the
solvent. Analysis of 1H NMR shows that the inhibitor can be isolated from either aerobic or
candle jar environment. The 1H NMR spectra shows that the inhibitory molecule has a
characteristic peak signal between 3.5 to 4.0 ppm in all environments.
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CONCLUSION
There is an emerging threat of Neisseria gonorrhoeae strains that are resistant to all
antibiotics. Because of this, the purpose of this research is to isolate, analyze, and partially
characterize a new inhibitor(s) of N. gonorrhoeae. Since there is an unknown molecule secreted by
C. albicans that inhibits N. gonorrhoeae, this molecule was partially characterized using 1H NMR
spectroscopy to assist in the development of a new antibiotic compound. Analysis of the 1H NMR
spectra from quorum-sensing molecules and the inhibitor showed that the inhibitor is not a
quorum-sensing molecule secreted by C. albicans. Along with this, it was concluded that liquid
chocolate agar and salts-based media retained inhibitory activity. Analysis of this 1H NMR of the
inhibitor, suggested that the inhibitor can be isolated from either the aerobic or candle jar
environment for both liquid chocolate and salt-based media because a clear peak between 3.5
and 4.0 ppm was observed in all spectra. The peaks represented by the inhibitor cannot be fully
characterized and thus, either correspond to a single molecule or a complex molecular structure.
It can be concluded that the inhibitor secreted by C. albicans to inhibit N. gonorrhoeae is a new
unknown compound. Future studies must be conducted to fully characterize the inhibitory
molecule and isolate the inhibitor in large concentration.
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